Showing results (631-640 of 928) with videos related to
Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|February 27, 2016
Male hormonal contraception: hope and promiseKatarzyna Piotrowska, Christina Wang, Ronald S Swerdloff, et al.The Lancet. Diabetes & Endocrinology|December 4, 2015
Post-transplantation diabetes-state of the artAdnan Sharif, Solomon CohneyThe Lancet. Diabetes & Endocrinology|March 13, 2016
Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitusChristian Seerup Frandsen, Thomas Fremming Dejgaard, Sten MadsbadThe Lancet. Diabetes & Endocrinology|December 4, 2014
The need for annual echocardiography to detect cabergoline-associated valvulopathy in patients with prolactinoma: a systematic review and additional clinical dataCarmela Caputo, David Prior, Warrick J InderThe Lancet. Diabetes & Endocrinology|January 27, 2018
Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban MalawiAlison J Price, Amelia C Crampin, Alemayehu Amberbir, et al.The Lancet. Diabetes & Endocrinology|December 13, 2017
Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategiesChristoph J Auernhammer, Christine Spitzweg, Martin K Angele, et al.The Lancet. Diabetes & Endocrinology|March 5, 2018
Do sulphonylureas still have a place in clinical practice?Kamlesh Khunti, Sudesna Chatterjee, Hertzel C Gerstein, et al.The Lancet. Diabetes & Endocrinology|August 14, 2015
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trialDick de Zeeuw, Pirow Bekker, Elena Henkel, et al.The Lancet. Diabetes & Endocrinology|May 27, 2017
Bone disease in diabetes: another manifestation of microvascular disease?Vikram V Shanbhogue, Stinus Hansen, Morten Frost, et al.The Lancet. Diabetes & Endocrinology|May 20, 2018
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trialSandrine Lablanche, Marie-Christine Vantyghem, Laurence Kessler, et al.Pageof 93